-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Inspire Medical Systems, Raises Price Target to $91

Benzinga·12/23/2025 15:12:08
Listen to the news
UBS analyst Danielle Antalffy maintains Inspire Medical Systems (NYSE:INSP) with a Neutral and raises the price target from $89 to $91.